前往化源商城

齐德巴坦(Zidebactam)

更新时间:2021-05-13 09:40:33

常用名 齐特巴坦 CAS号 1436861-97-0
价格 ¥需询单/100mg ¥需询单/1g 纯度 98.0%
备货期 需询单 库存 询单
 产品详情(用途,包装等)
Zidebactam and WCK 5153 are novel β-lactam enhancers that are bicyclo-acyl hydrazides (BCH), derivatives of the diazabicyclooctane (DBO) scaffold, targeted for the treatment of serious infections caused by highly drug-resistant Gram-negative pathogens. In this study, we determined the penicillin-binding protein (PBP) inhibition profiles and the antimicrobial activities of zidebactam and WCK 5153 against Pseudomonas aeruginosa, including multidrug-resistant (MDR) metallo-β-lactamase (MBL)-producing high-risk clones. MIC determinations and time-kill assays were conducted for zidebactam, WCK 5153, and antipseudomonal β-lactams using wild-type PAO1, MexAB-OprM-hyperproducing (mexR), porin-deficient (oprD), and AmpC-hyperproducing (dacB) derivatives of PAO1, and MBL-expressing clinical strains ST175 (blaVIM-2) and ST111 (blaVIM-1). Furthermore, steady-state kinetics was used to assess the inhibitory potential of these compounds against the purified VIM-2 MBL. Zidebactam and WCK 5153 showed specific PBP2 inhibition and did not inhibit VIM-2 (apparent Ki [Kiapp] > 100 μM). MICs for zidebactam and WCK 5153 ranged from 2 to 32 μg/ml (amdinocillin MICs > 32 μg/ml). Time-kill assays revealed bactericidal activity of zidebactam and WCK 5153. LIVE-DEAD staining further supported the bactericidal activity of both compounds, showing spheroplast formation. Fixed concentrations (4 or 8 μg/ml) of zidebactam and WCK 5153 restored susceptibility to all of the tested β-lactams for each of the P. aeruginosa mutant strains. Likewise, antipseudomonal β-lactams (CLSI breakpoints), in combination with 4 or 8 μg/ml of zidebactam or WCK 5153, resulted in enhanced killing. Certain combinations determined full bacterial eradication, even with MDR MBL-producing high-risk clones. β-Lactam–WCK enhancer combinations represent a promising β-lactam “enhancer-based” approach to treat MDR P. aeruginosa infections, bypassing the need for MBL inhibition.

供应商信息

河北唯特医药科技有限公司

认证状态:未认证供应商
电话:13180081292
地址:河北省石家庄高新区泰山街219-19号二楼
地区: 河北省 石家庄市 裕华区
联系人:王经理
联系人电话:13180081292
邮件:wetogethermeditech@163.com
网址:http://www.wetogethermed.com
主要市场:中国大陆,日本,印度
年贸易额:100w
外贸占销售比例:
主要合作伙伴:
河北唯特医药科技有限公司专注于抗生素增强剂(Antibiotic enhancer)的研发和生产,尤其以β内酰胺酶抑制剂类管线的药物为业务主线,提供阿维巴坦(Avibactam),瑞莱巴坦(Relebactam),齐德巴坦(Zidebactam),法硼巴坦(Vaborbactam),WCK-5153,等一系列β内酰胺酶抑制剂的API, 中间体,杂质,研发生产,技术服务和技术转让列服务。
推荐生产厂家/供应商:我要出现这里




查看所有供应商和价格请点击:

齐特巴坦生产厂家


参考价格:¥5500/5 mg
其他供应商价格:
2024-07-15 Zidebactam
价格:需询单
2022-11-29 Zidebactam
价格:¥需询单
2022-09-23 Zidebactam
价格:¥15556.0
2024-06-26 Zidebactam
价格:¥需询单

查看所有价格,请点击齐特巴坦价格